Equity · Healthcare
VERA
NASDAQVera Therapeutics (VERA)
The line runs $32.11 on 31 July through $30.95 on 28 October, on a scale from $25 to $40. Days the market did not trade hold the previous close, flat.
- Market cap
- $2.2B
- 52-week range
- $24 – $55.71
- Avg volume
- 96.5K
- Mentions, 30 days
- 11
- Net sentiment
- +0.15
as of Oct 27, 2026
Have Vera Therapeutics (VERA) insiders bought or sold shares recently?
In the 90 days to 29 Oct 2026, Vera Therapeutics insiders reported 2 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 11 Dec 2025.
Form 4, 90 days to 29 Oct 2026, newest reported trade 15 Sep 2026
Buys 0Sells 2Net sold $1.33MOther filings 4
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 15 Sep 2026 | Fordyce MarshallPRESIDENT AND CEO | Sell | 18,500 | $685K |
| 02 Sep 2026 | Fordyce MarshallPRESIDENT AND CEO | Sell | 18,500 | $650K |
| Sold | 2 open-market sales | 37,000 | $1.33M |
4 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 15 Sep 2026 | Fordyce MarshallPRESIDENT AND CEO | Option exercise | 18,500 | $54K |
| 11 Sep 2026 | Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR | Option exercise | 5,000 | $20K |
| 02 Sep 2026 | Fordyce MarshallPRESIDENT AND CEO | Option exercise | 18,500 | $54K |
| 03 Aug 2026 | Boman Nancy LeeChief Regulatory Officer | Award | 44,987 |
Which funds hold Vera Therapeutics (VERA)?
9 of the 45 institutional funds we track reported a Vera Therapeutics position for the quarter ended 30 Jun 2026 — a combined $52.6M; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Balyasny Asset Management | Held (±25%) | 374,951 | $16.1M | −10.6% |
| Renaissance Technologies | Trimmed | 279,528 | $12.0M | −38.9% |
| Millennium Management | Held (±25%) | 278,658 | $12.0M | −5.1% |
| Two Sigma Investments | Trimmed | 104,170 | $4.5M | −50.4% |
| D. E. Shaw & Co. | Added | 74,509 | $3.2M | +1,254.7% |
| Man Group | Held (±25%) | 50,346 | $2.2M | −5.4% |
| Point72 Asset Management | Trimmed | 40,563 | $1.7M | −96.6% |
| AQR Capital Management | Held (±25%) | 16,173 | $694K | +1.0% |
| Marshall Wace | New position | 7,531 | $323K | |
| Citadel Advisors | Exited |
What has been filed or recorded for Vera Therapeutics (VERA)?
The filings we hold for Vera Therapeutics, newest first: 5 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 25 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 25 Sep 2026 | Fails to deliver | Shares failed to deliver | 66 shares | $2K notional · <0.001% of shares out |
| 22 Sep 2026 | Fails to deliver | Shares failed to deliver | 604 shares | $21K notional · 0.001% of shares out |
| 21 Sep 2026 | Fails to deliver | Shares failed to deliver | 484 shares | $16K notional · 0.001% of shares out |
| 16 Sep 2026 | Fails to deliver | Shares failed to deliver | 15 shares | $505 notional · <0.001% of shares out |
| 14 Sep 2026 | Fails to deliver | Shares failed to deliver | 14 shares | $491 notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −$1.52 | |
| 30 Jun 2026 | Financials | Total assets | $533.0M | at period end |
| 30 Jun 2026 | Financials | Total equity | $407.8M | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −$1.69 | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −$4.66 | |
| 31 Dec 2025 | Financials | Net income | −$299.6M | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −$4.66 | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −$1.26 | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −$1.20 | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −$0.81 | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −$2.75 | |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −$0.85 |
What is Reddit saying about Vera Therapeutics (VERA)?
Reddit mentioned VERA 11 times in the 30 days to 29 October 2026, across 5 of the communities we track. All of them were scored for sentiment: 73% read bullish, 0% bearish and 27% neither. Reddit data updated 29 October 2026.
30-day window, Method
Mentions, 30 days 11Bullish 73%Bearish 0%Communities 5Against the market +19 points
How do Reddit mentions of Vera Therapeutics (VERA) compare with its price?
Share ↗
Where Vera Therapeutics (VERA) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 55% | 6 | +0.07 |
| r/stocks | 18% | 2 | +0.27 |
| r/investing | 9% | 1 | +0.29 |
| r/asx | 9% | 1 | +0.21 |
| r/cryptocurrency | 9% | 1 | +0.19 |
Moves with Vera Therapeutics (VERA)
Tickers whose daily Reddit volume rose and fell with Vera Therapeutics (VERA)'s. Co-discussion, not price.
POET +0.64ZM +0.63TOT +0.63POWW +0.62WMT +0.58RCAT +0.58
How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations), Method
Vera Therapeutics (VERA): frequently asked questions
What did Vera Therapeutics shares close at?
Vera Therapeutics closed at $30.95 on 28 Oct 2026, up 3.17% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Vera Therapeutics’ market cap?
Vera Therapeutics is worth $2.2B by market value as of 27 Oct 2026, which is the share price times the shares on issue from its SEC filings.
Have Vera Therapeutics insiders bought or sold shares recently?
In the 90 days to 29 Oct 2026, Vera Therapeutics insiders reported 2 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 11 Dec 2025. A further 4 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Vera Therapeutics?
9 of the 45 funds we track reported a Vera Therapeutics position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Balyasny Asset Management, Renaissance Technologies and Millennium Management. See Funds
When did Vera Therapeutics last report earnings?
Vera Therapeutics last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$1.52; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Vera Therapeutics?
Vera Therapeutics was mentioned 1 times in the last 7 days across the finance subreddits we track, and 11 times over the trailing 30 days. Of the 11 mentions scored for sentiment, 73% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings